XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
In 2018, our stockholders approved the adoption of the SenesTech, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan has since been amended and restated on certain occasions, most recently on June 23, 2023, when our stockholders approved an increase to the total number of authorized shares to 70,717 shares.
Stock options are generally issued with a per share exercise price equal to the fair market value of our common stock at the date of grant. Options granted generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods, with terms of generally five years. Certain stock option awards provide for accelerated vesting upon a change in control.
As of December 31, 2023, we had 42,008 shares of common stock available for issuance under the 2018 Plan.
Stock Options
We measure the fair value of stock options with service-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The Black-Scholes valuation model requires us to make certain estimates and assumptions, including assumptions related to the expected price volatility of our stock, the period during which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for our stock.
Fair value of options granted is determined using the Black-Scholes option-pricing model with the following weighted average assumptions:
20232022
Risk-free interest rate5.3 %3.7 %
Expected dividend yield— %— %
Expected volatility128 %90.5 %
Expected term (in years)5.03.3
The weighted average fair value of options granted during the years ended December 31, 2023 and 2022 was $14.88 and $41.04 per share, respectively. The risk-free interest rate is estimated using treasury bill interest rates. The expected dividend yield is no as we have not paid any dividends to date and do not expect to pay dividends in the future. Expected volatility is estimated based on the historical volatility of our common stock over the expected term as this represents our best estimate of future volatility. The contractual life of stock options granted is five years, and we have elected to use the “simplified method” to estimate expected term. Under the simplified method, an option’s expected term is calculated as the average of its vesting period and original contractual life. For non-employee options, the expected term of options granted is the contractual term of the options.
The stock option activity consists of the following:
Number of
Options
Weighted
Average
Exercise
Price Per
Share
Weighted
Average
Remaining
Contractual
Term
(years)
Aggregate
Intrinsic
Value (1)
Outstanding as of December 31, 20214,533$2,071.20 3.9$— 
Granted20,16369.48 5.0— 
Exercised— — 
Forfeited(1,278)— — 
Expired(16)— — 
Outstanding as of December 31, 202223,402204.00 3.9— 
Granted16,61615.00 5.0— 
Exercised— — 
Forfeited(3,282)— — 
Expired(28)— — 
Outstanding as of December 31, 202336,708119.70 4.0— 
Exercisable as of December 31, 202320,634
(2)
154.31 3.8— 
(1)
Calculated based on the difference between the estimated fair value of our stock and the exercise price of the underlying option. The estimated stock values used in the calculation was $15.00 and $71.52 per share for the years ended December 31, 2023 and 2022, respectively.
(2)
Includes options related to 8,249 shares that are inducement awards and not granted under the 2018 Plan.
As of December 31, 2023, the unrecognized stock-based compensation cost was $293,000, which is expected to be recognized over a weighted average period of 13 months.
Restricted Stock Units
The restricted stock unit activity consists of the following:
Number of
Units
Weighted Average
Grant Date Fair Value Per Unit
Outstanding as of December 31, 20212$432.00 
Granted1,58734.44 
Vested(23)212.04 
Forfeited— 
Outstanding as of December 31, 20221,56632.52 
Granted— 
Vested(1,566)32.52 
Forfeited— 
Outstanding as of December 31, 2023— 
The stock-based compensation expense was recorded as following (in thousands):
Years Ended December 31,
20232022
Research and development$17 $
General and administrative538 
(1)
708 
Total stock-based compensation expense$555 $711 
(1)
Includes $100,000 related to stock issued in exchange for marketing services.